- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Reutilization of VMA spot test for neuroblastoma in modern medicine
-
- Noguchi Kazuhiro
- Department of Pediatrics, Kanazawa University
-
- Nishimura Ryosei
- Department of Pediatrics, Kanazawa University
-
- Araki Raita
- Department of Pediatrics, Kanazawa University
-
- Fukuda Masaki
- Department of Pediatrics, Kanazawa University
-
- Fujiki Toshihiro
- Department of Pediatrics, Kanazawa University
-
- Kuroda Rie
- Department of Pediatrics, Kanazawa University
-
- Ikawa Yasuhiro
- Department of Pediatrics, Kanazawa University
-
- Maeba Hideaki
- Department of Pediatrics, Kanazawa University
-
- Yachie Akihiro
- Department of Pediatrics, Kanazawa University
Bibliographic Information
- Other Title
-
- 現在の神経芽腫診療におけるVMAスポット法の再評価
Search this article
Description
<p>Urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) detection is useful as an adjunct to the diagnosis of neuroblastoma. Previously, the “VMA spot test” was the only method of detecting urinary VMA. However, the spot test tended to yield false-positive results. Instead of the spot test, high-performance liquid chromatography (HPLC) is widely used nowadays. We have known that neither VMA nor HVA levels are elevated in approximately 10% of neuroblastoma patients. However, even in one-half of cases of such tumors, catecholamines or related metabolites were more or less secreted. Some previous studies demonstrated that the VMA spot test could detect various catecholamines and their metabolites, which are not specific for VMA. We have successfully identified two cases of VMA-negative neuroblastoma in the early phase on the basis of the positive results of the VMA spot test. In patients with tumors detected by image inspection, the VMA spot test would be a powerful tool for identifying neuroblastoma, even if the patients are negative for VMA and HVA.</p>
Journal
-
- The Japanese Journal of Pediatric Hematology / Oncology
-
The Japanese Journal of Pediatric Hematology / Oncology 55 (3), 284-287, 2018
The Japanese Society of Pediatric Hematology / Oncology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282763060676736
-
- NII Article ID
- 130007501674
-
- ISSN
- 21895384
- 2187011X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed